Literature DB >> 19996106

Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release.

Linda Lin-yan Wu1, Yongjun Fan, Shihua Li, Xiao-Jiang Li, Xin-Fu Zhou.   

Abstract

Brain-derived neurotrophic factor (BDNF) plays a pivotal role in brain development and synaptic plasticity. It is synthesized as a precursor (pro-BDNF), sorted into the secretory pathway, transported along dendrites and axons, and released in an activity-dependent manner. Mutant Huntingtin with expanded polyglutamine (polyQ) and the V66M polymorphism of BDNF reduce the dendritic distribution and axonal transport of BDNF. However, the mechanism underlying this defective transport remains unclear. Here, we report that Huntingtin-associated protein-1 (HAP1) interacts with the prodomain of BDNF and that the interaction was reduced in the presence of polyQ-expanded Huntingtin and BDNF V66M. Consistently, there was reduced coimmunoprecipitation of pro-BDNF with HAP1 in the brain homogenate of Huntington disease. Pro-BDNF distribution in the neuronal processes and its accumulation in the proximal and distal segments of crushed sciatic nerve and the activity-dependent release of pro-BDNF were abolished in HAP1(-/-) mice. These results suggest that HAP1 may participate in axonal transport and activity-dependent release of pro-BDNF by interacting with the BDNF prodomain. Accordingly, the decreased interaction between HAP1 and pro-BDNF in Huntington disease may reduce the release and transport of BDNF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19996106      PMCID: PMC2820788          DOI: 10.1074/jbc.M109.073197

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

Review 1.  Acute and long-term synaptic modulation by neurotrophins.

Authors:  Bai Lu
Journal:  Prog Brain Res       Date:  2004       Impact factor: 2.453

Review 2.  Dynein: An ancient motor protein involved in multiple modes of transport.

Authors:  Richard B Vallee; John C Williams; Dileep Varma; Lora E Barnhart
Journal:  J Neurobiol       Date:  2004-02-05

Review 3.  Cargo-carrying motor vehicles on the neuronal highway: transport pathways and neurodegenerative disease.

Authors:  Shermali Gunawardena; Lawrence S B Goldstein
Journal:  J Neurobiol       Date:  2004-02-05

4.  Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits.

Authors:  Eiji Shimizu; Kenji Hashimoto; Masaomi Iyo
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-04-01       Impact factor: 3.568

5.  Neurotrophin-4, alone or heterodimerized with brain-derived neurotrophic factor, is sorted to the constitutive secretory pathway.

Authors:  Andrew P Hibbert; Stephen J Morris; Nabil G Seidah; Richard A Murphy
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

6.  Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.

Authors:  Laurent R Gauthier; Bénédicte C Charrin; Maria Borrell-Pagès; Jim P Dompierre; Hélène Rangone; Fabrice P Cordelières; Jan De Mey; Marcy E MacDonald; Volkmar Lessmann; Sandrine Humbert; Frédéric Saudou
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

7.  A cell-based screen for drugs to treat Huntington's disease.

Authors:  Charity T Aiken; Allan J Tobin; Erik S Schweitzer
Journal:  Neurobiol Dis       Date:  2004-08       Impact factor: 5.996

8.  Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism.

Authors:  Tara L Spires; Helen E Grote; Neelash K Varshney; Patricia M Cordery; Anton van Dellen; Colin Blakemore; Anthony J Hannan
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

9.  Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons.

Authors:  Zhe-Yu Chen; Paresh D Patel; Gayatree Sant; Chui-Xiang Meng; Kenneth K Teng; Barbara L Hempstead; Francis S Lee
Journal:  J Neurosci       Date:  2004-05-05       Impact factor: 6.167

10.  Sortilin is essential for proNGF-induced neuronal cell death.

Authors:  Anders Nykjaer; Ramee Lee; Kenneth K Teng; Pernille Jansen; Peder Madsen; Morten S Nielsen; Christian Jacobsen; Marco Kliemannel; Elisabeth Schwarz; Thomas E Willnow; Barbara L Hempstead; Claus M Petersen
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

View more
  36 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  HAP1 Is Required for Endocytosis and Signalling of BDNF and Its Receptors in Neurons.

Authors:  Yoon Lim; Linda Lin-Yan Wu; Si Chen; Ying Sun; Swarna Lekha Vijayaraj; Miao Yang; Larisa Bobrovskaya; Damien Keating; Xiao-Jiang Li; Xin-Fu Zhou
Journal:  Mol Neurobiol       Date:  2017-01-12       Impact factor: 5.590

Review 3.  The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease.

Authors:  David Blum; Yijuang Chern; Maria Rosaria Domenici; Luc Buée; Chien-Yu Lin; William Rea; Sergi Ferré; Patrizia Popoli
Journal:  J Caffeine Adenosine Res       Date:  2018-06-01

4.  Activation of the sigma-1 receptor by haloperidol metabolites facilitates brain-derived neurotrophic factor secretion from human astroglia.

Authors:  Dhwanil A Dalwadi; Seongcheol Kim; John A Schetz
Journal:  Neurochem Int       Date:  2017-02-08       Impact factor: 3.921

5.  HAP1 helps to regulate actin-based transport of insulin-containing granules in pancreatic β cells.

Authors:  Zhiyong Wang; Ting Peng; Hongnian Wu; Jun He; He Li
Journal:  Histochem Cell Biol       Date:  2015-03-06       Impact factor: 4.304

6.  Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Authors:  Bronwen Martin; Wayne Chadwick; Wei-na Cong; Nick Pantaleo; Caitlin M Daimon; Erin J Golden; Kevin G Becker; William H Wood; Olga D Carlson; Josephine M Egan; Stuart Maudsley
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

7.  Precursor of brain-derived neurotrophic factor (proBDNF) forms a complex with Huntingtin-associated protein-1 (HAP1) and sortilin that modulates proBDNF trafficking, degradation, and processing.

Authors:  Miao Yang; Yoon Lim; Xiaojiang Li; Jin-Hua Zhong; Xin-Fu Zhou
Journal:  J Biol Chem       Date:  2011-02-28       Impact factor: 5.157

Review 8.  Mesenchymal stem cells for the treatment of neurodegenerative disease.

Authors:  Nanette Joyce; Geralyn Annett; Louisa Wirthlin; Scott Olson; Gerhard Bauer; Jan A Nolta
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

9.  Huntingtin-associated protein 1 regulates exocytosis, vesicle docking, readily releasable pool size and fusion pore stability in mouse chromaffin cells.

Authors:  Kimberly D Mackenzie; Michael D Duffield; Heshan Peiris; Lucy Phillips; Mark P Zanin; Ee Hiok Teo; Xin-Fu Zhou; Damien J Keating
Journal:  J Physiol       Date:  2013-12-23       Impact factor: 5.182

10.  Mesenchymal stem cells for trinucleotide repeat disorders.

Authors:  Geralyn Annett; Gerhard Bauer; Jan A Nolta
Journal:  Methods Mol Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.